ESR1 and breast carcinoma: In ER+ breast cancer cell line, MCF-7, combination treatments of chemotherapeutics tamoxifen, taxol and cisplatin with 1 mg/mL HE did not show any significant change in apoptosis induction when compared to individual treatments (Fig. 3a).